Low serum LDL cholesterol in patients with type 2 diabetes: An analysis on two different patient populations

International Journal of Cardiology

Volumn 144, Issue 3, 2010, Pages 394-398

  Saely, Christoph H ^a,b,c   Eber, Bernd ^d   Pfeiffer, Karl P ^e   Drexel, Heinz ^a,b,c,f  

^a Vorarlberg Institute for Vascular Investigation and Treatment VIVIT   (Austria)

^b Academic Teaching Hospital Feldkirch   (Austria)

^c PRIVATE UNIVERSITY OF THE PRINCIPALITY OF LIECHTENSTEIN   (Liechtenstein)

^d Kreuzschwestern Hospital   (Austria)

^e INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^f DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Coronary artery disease; Hypertension; LDL cholesterol; Lipoproteins; Type 2 diabetes

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA GLUCOSIDASE INHIBITOR; ANGIOTENSIN RECEPTOR ANTAGONIST; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIGUANIDE DERIVATIVE; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SULFONYLUREA; TRIACYLGLYCEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CHOLESTEROL BLOOD LEVEL; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

AGED; ALGORITHMS; APOLIPOPROTEINS; AUSTRIA; BIOLOGICAL MARKERS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RISK FACTORS; TRIGLYCERIDES;

EID: 77957887769     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.04.048     Document Type: Article

References (25)

1. W.A. Muller Diabetes mellitus-long time survival J Insur Med 30 1998 17 27
2. L.N. McEwen, C. Kim, and A.J. Karter Risk factors for mortality among patients with diabetes: the Translating Research Into Action for Diabetes (TRIAD) Study Diabetes Care 30 2007 1736 1741
3. K.G. Alberti, and P.Z. Zimmet Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabet Med 15 1998 539 553
4. M.R. Taskinen Diabetic dyslipidaemia: from basic research to clinical practice Diabetologia 46 2003 733 749
5. H. Drexel, S. Aczel, and T. Marte Is atherosclerosis in diabetes and impaired fasting glucose driven by elevated LDL cholesterol or by decreased HDL cholesterol? Diabetes Care 28 2005 101 107
6. R.C. Turner, H. Millns, and H.A. Neil Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23) BMJ 316 1998 823 828
7. P.M. Kearney, L. Blackwell, and R. Collins Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis Lancet 371 2008 117 125
8. S.M. Grundy, J.I. Cleeman, and C.N. Merz Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 2004 227 239
9. C.H. Saely, L. Koch, and F. Schmid Adult Treatment Panel III 2001 but not International Diabetes Federation 2005 criteria of the metabolic syndrome predict clinical cardiovascular events in subjects who underwent coronary angiography Diabetes Care 29 2006 901 907
10. A.V. Chobanian, G.L. Bakris, and H.R. Black The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA 289 2003 2560 2572
11. H. Drexel, F.W. Amann, and J. Beran Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis Circulation 90 1994 2230 2235
12. B. Dahlof, R.B. Devereux, and S.E. Kjeldsen Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol Lancet 359 2002 995 1003 (Pubitemid 34286536)
13. F.M. Sacks, A.M. Tonkin, and T. Craven Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors Circulation 105 2002 1424 1428
14. R. Collins, J. Armitage, S. Parish, P. Sleigh, and R. Peto MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial Lancet 361 2003 2005 2016
15. S.M. Haffner, S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N Engl J Med 339 1998 229 234
16. J.H. Stein, and R.S. Rosenson Lipoprotein Lp(a) excess and coronary heart disease Arch Intern Med 157 1997 1170 1176
17. C.H. Saely, L. Koch, and F. Schmid Lipoprotein(a), type 2 diabetes and vascular risk in coronary patients Eur J Clin Invest 36 2006 91 97
18. G. Walldius, and I. Jungner Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy J Intern Med 255 2004 188 205
19. A.C. St Pierre, B. Cantin, and G.R. Dagenais Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Quebec Cardiovascular Study Arterioscler Thromb Vasc Biol 25 2005 553 559 (Pubitemid 40315677)
20. C. Baigent, A. Keech, and P.M. Kearney Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 2005 1267 1278
21. AIM HIGH: Niacin Plus Statin to Prevent Vascular Events 2008 [article online], Available from http://www.clinicaltrials.gov/ct/search;jsessionid= 4E2ACC100CC16E33C16014B5C7E06531?term=Aim-high. Accessed 26 October 2007
22. Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE 2008 [article online], Available from http://www.clinicaltrials.gov/ct2/show/ NCT00461630?term=hps+thrive&rank=1. Accessed 26 October 2007
23. H.N. Ginsberg, D.E. Bonds, and L.C. Lovato Evolution of the lipid trial protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial Am J Cardiol 99 2007 56i 67i
24. The Epidemiology of Diabetes Mellitus. An International Perspective 2001 John Wiley and Sons
25. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150